H.C. Wainwright raises Incyte stock price target on Atebrioz approval

🌐 Investing.com (Cyprus) —
H.C. Wainwright raises Incyte stock price target on Atebrioz approval

AI Summary

H.C. Wainwright raised its price target for Incyte after the approval of Atebrioz. The headline does not specify the new target or provide details about the approval.

Markets Health Incyte Atebrioz drug approval price target H.C. Wainwright pharmaceuticals

Read original source →